Purple biotech appoints seasoned biopharmaceutical industry executive suzana nahum-zilberberg to board of directors

Rehovot, israel, may 19, 2021 (globe newswire) -- purple biotech ltd. ("purple biotech" ", or the "company") (nasdaq/tase: ppbt), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, today announced the appointment of suzana nahum-zilberberg, a seasoned biopharmaceutical industry executive, to its board of directors.
PPBT Ratings Summary
PPBT Quant Ranking